Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
401. |
ECCT/12/04/01 | A double-masked randomised placebo-controlled trial of adjuvant topical 5-fluorouracil (5FU) treatment following surgical excision of ocular surface squamous neoplasia. |
Principal Investigator(s) 1. Stephen Gichuhi Site(s) in Kenya 1. Kenyatta National Hospital (Nairobi City county) 2. PCEA Kikuyu Eye Unit (Kiambu county) 3. Sabatia Eye Hospital (Kakamega county) 4. Kitale District Hospital, Eye Unit (Trans Nzoia county) 5. Homa Bay District Hospital, Eye Unit (Homa Bay county) |
View |
402. |
ECCT/19/03/04 | NIFTY Non-Inferiority Fractional-Doses Trial For Yellow Fever Vaccine |
Principal Investigator(s) 1. George Warimwe Site(s) in Kenya KEMRI Kilifi |
View |
403. |
ECCT/17/08/01 | A trial to compare the safety and immune response of the normal full and reduced doses of yellow fever vaccines in Kenyan adults A Phase IV randomized, double blinded non-inferiority trial on the immunogenicity and safety of fractional doses of yellow fever vaccines. |
Principal Investigator(s) 1. Philip Bejon Site(s) in Kenya KEMRI Kilifi |
View |
404. |
ECCT/21/06/15 | Therapeutic Efficacy Study Efficacy of Artemether Lumefantrine (AL) and Dihydroartemisinin-Piperaquine (DHP) for the treatment of uncomplicated Plasmodium falciparum malaria in Siaya and Bungoma counties, Kenya. |
Principal Investigator(s) 1. Dr. Sarah-Blythe Ballard 2. Dr. Willis Akhwale 3. Dr. Grace Ikahu 4. Dr. George Githuka 5. Dr. Dickson Mtungu Mwakangalu 6. Dr. Elvis Omondi Oyugi 7. Hellen Gatakaa 8. Regina Jepkosgei Kandie 9. Dr. Fredrick Ouma Odhiambo Site(s) in Kenya 1. Mahonge Health Center (Bung\'oma county) 2. Kaluo Health Center (Siaya county) |
View |
405. |
ECCT/18/12/01 | study to determine if a new malaria vaccine is safe and induces immunity among Kenyan adults, young children and infants. A Phase 1b, open-label, age de-escalation, dose-escalation study to evaluate the safety and immunogenicity of different doses of a candidate malaria vaccine; adjuvanted R21(R21/MM) in adults, young children and infants in Kilifi, Kenya. |
Principal Investigator(s) 1. Mainga Hamaluba Site(s) in Kenya KEMRI-Wellcome Trust Research Programme (KWTRP) Centre for Geographic Medical Research - Coast (CGMRC), Kilifi, Kenya. |
View |